Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Adnexal Mass
- Ovarian Cancer
- Pelvic Mass
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
This is a prospective, international, multi-center, observational study with a goal of collecting de-identified samples and data from 1,200 women with a known pelvic mass. Participants will consent to baseline and follow-up data and biospecimen collections.
This is a prospective, international, multi-center, observational study with a goal of collecting de-identified samples and data from 1,200 women with a known pelvic mass. Participants will consent to baseline and follow-up data and biospecimen collections.
Tracking Information
- NCT #
- NCT03837327
- Collaborators
- Not Provided
- Investigators
- Study Chair: Klaus Lindpaintner, MD Venn Biosciences Corporation
Get Well Soon